Global advanced wound care market analysis and insights
The global advanced wound care market estimated at US$10.84 billion in the year 2022 is now projected to grow at a CAGR of 5.64% and reach US$15.91 billion by 2028. The rising prevalence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is fueling the demand for advanced wound care products and therapies. As the global population ages and the incidence of chronic diseases increases, there is a growing need for advanced solutions that can accelerate the wound healing process and reduce the risk of complications.
Another driving factor is the continuous technological advancements in wound care products, including the development of novel materials, smart dressings, and advanced therapeutic devices. Innovations such as bioactive dressings, growth factors, and stem cell therapies are enhancing the efficacy of wound care treatments, contributing to the market’s expansion. Moreover, the increasing awareness among healthcare professionals and patients about the benefits of advanced wound care products is driving adoption.
Looking ahead, the future growth potential of the advanced wound care market lies in the expanding applications of regenerative medicine and personalized medicine approaches. Regenerative therapies, such as tissue engineering and stem cell-based treatments, hold promise for promoting tissue regeneration and addressing complex wounds. Additionally, the integration of digital technologies and telemedicine in wound care management provides opportunities for remote monitoring and personalized care, further shaping the landscape of the advanced wound care market. Overall, the convergence of scientific advancements, demographic trends, and healthcare awareness is likely to propel the market’s growth and open new avenues for innovation and investment.
Advanced wound care regional market insights
North American advanced wound care market is expected to grow significantly over the forecast period 2022-2028. This growth can be attributed to the high incidence of chronic diseases and the presence of major market players in the region. United States contributed around 84% of the total North American advanced wound care market. It is estimated to have a market value of US$3.72 billion in the year 2022. Among the other noteworthy geographic markets are Canada and Mexico, each forecast to grow at 3.36% and 5.13% respectively over the 2022-2028 period.
Asia Pacific advanced wound care market is anticipated to witness an upsurge owing to the increase in healthcare expenditure, a rise in the number of surgical procedures, and a growing awareness of the importance of wound care in the region. High R&D expenditure by major players, combined with efforts to commercialize advanced wound care products at affordable prices, offer a huge growth potential over the next five years. China is expected to dominate the Asia-Pacific market and reach a market size of US$2.19 billion by 2028.
Within Europe, Germany, France, Italy and the U.K. are the key countries responsible for the significant growth of the regional market. Germany is expected to grow at a fastest CAGR of 4.85% over the forecast period.
Meanwhile, the Middle East & Africa is expected to show limited growth due to the strong presence of under-developed countries in Africa who are still struggling to meet technology standards. However, any growth that the region experiences is expected to come from developing Middle Eastern nations such as Qatar, U.A.E, and Oman due to a similar growth pattern as the Asia Pacific.
Key players
Key players profiled in the report include 3M Company; Absorbest; Advanced Medical Solutions Group plc; Anika Therapeutics, Inc.; AOTI Inc.; Argentum Medical LLC (Silverlon); Avery Dennison Corporation; Axio Biosolutions Private Limited; B. Braun Melsungen AG; Baxter; BioCure, Inc.; BioMonde; Biovotec AS; Cardinal Health, Inc.; Carilex Medical GmbH; Coloplast A/S; Convatec Group PLC; Ethicon, Inc.; Integra LifeSciences; LifeNet Health; Medtronic plc; MIMEDX Group, Inc.; Mölnlycke Health Care AB; Organogenesis Inc.; PAUL Hartmann AG; Smith & Nephew; Urgo Medical, among others.
Competitive Landscape
November 16, 2023 – Johnson & Johnson MedTech’s Ethicon, a surgical instruments maker, has received the CE Mark for the ETHIZIA haemostatic sealing patch. ETHIZIA is an adjunctive haemostat solution designed to achieve sustained haemostasis in difficult to control bleeding conditions. Made from synthetic polymer technology, the sealing patch is said to be the first and only haemostatic matrix designed to be equally effective and active on both sides. According to Ethicon, the patch allows easy handling in both open and minimally invasive procedures due to its maximum adaptability design.
October 12, 2023 – MediWound Ltd., a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced collaboration with 3M Health Care. 3M Health Care will provide its market leading two-layer compression systems Coban™ 2 and Coban™ 2 Lite to be used during the debridement and wound healing phases of the EscharEx Phase III study.
Advanced wound care market scope
- By product type
- Advanced dressings
- Therapy devices
- Active wound care
- Topical agents
- Others
- By application
- Chronic wounds
- Acute wounds
- By end-user
- Hospitals and clinics
- Wound care centres
- Home healthcare
- Ambulatory surgical centers
- Others
- By region
- North America
- South America
- Europe
- Asia Pacific
- Middle East and Africa
| Report Attribute | Details |
| No. of Pages | 278 |
| Published | November-2023 |
| Forecast Period | 2022-2028 |
| Estimated Market Size in 2022 | US$10.84 billion |
| Forecasted Market Size by 2028 | US$15.91 billion |
| CAGR | 5.64% |
| Regions Covered | North America, South America, Europe, Asia Pacific, Middle East and Africa |
| Companies Mentioned | 3M Company; Absorbest; Advanced Medical Solutions Group plc; Anika Therapeutics, Inc.; AOTI Inc.; Argentum Medical LLC (Silverlon); Avery Dennison Corporation; Axio Biosolutions Private Limited; B. Braun Melsungen AG; Baxter; BioCure, Inc.; BioMonde; Biovotec AS; Cardinal Health, Inc.; Carilex Medical GmbH; Coloplast A/S; Convatec Group PLC; Ethicon, Inc.; Integra LifeSciences; LifeNet Health; Medtronic plc; MIMEDX Group, Inc.; Mölnlycke Health Care AB; Organogenesis Inc.; PAUL Hartmann AG; Smith & Nephew; Urgo Medical, among others. |
The research report provides a comprehensive review of market trends (Technology, Product and Application analysis), market growth drivers, PEST Analysis (Political, Economic, Social and Technological Analysis) Market growth inhibitors, and strategic industry activities and SWOT Analysis of key players in the market. The report provides market estimates and forecast for geographic markets such as the North America (United States, Canada, Mexico and Rest of North America), South America (Brazil, Argentina Chile Colombia Peru Venezuela Ecuador and Rest of South America), Europe (Germany, France, U.K., Russia, Italy, Spain, Sweden, Netherlands, Poland, Austria, Belgium, Finland, Norway, Switzerland, Denmark, Czech Republic, Portugal and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Philippines, Malaysia and Rest of Asia-Pacific), Middle East (Iran, Turkey, Kuwait, UAE, Israel, Oman, Bahrain, Saudi Arabia, Qatar, Egypt and Rest of Middle East) & Africa.
Research Methodology
